You have 9 free searches left this month | for more free features.

tazemetostat

Showing 1 - 25 of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

T-cell Lymphoma, CLL/SLL Trial in Birmingham (Tazemetostat, Acalabrutinib and Tazemetostat)

Not yet recruiting
  • T-cell Lymphoma
  • CLL/SLL
  • Tazemetostat
  • Acalabrutinib and Tazemetostat
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 11, 2023

Peripheral Nerve Sheath Tumor Trial in Gainesville (Tazemetostat)

Recruiting
  • Peripheral Nerve Sheath Tumor
  • Tazemetostat
  • Gainesville, Florida
    University of Florida
Jan 4, 2023

Relapsed/Refractory Lymphoma Trial in Shanghai (tazemetostat, HMPL-689)

Not yet recruiting
  • Relapsed/Refractory Lymphoma
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Feb 2, 2023

Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

Suspended
  • Solid Tumor
  • ARID1A Gene Mutation
  • Tazemetostat
  • Greenville, South Carolina
    Prisma Health Cancer Institute
Jan 10, 2023

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • New York, New York
    Weill Cornell Medicine/NewYork-Presberteryian Hospital
Jan 18, 2023

Follicular Lymphoma Trial (Bendamustine, Rituximab, Tazemetostat)

Not yet recruiting
  • Follicular Lymphoma
  • (no location specified)
Dec 15, 2022

Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Boston (TAZEMETOSTAT, Zandelisib)

Not yet recruiting
  • Relapsed Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Boston, Massachusetts
  • +1 more
Oct 28, 2022

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Trial in Isehara, Chuo-ku (tazemetostat)

Completed
  • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
  • Tazemetostat
  • Isehara, Kanagawa, Japan
  • +1 more
Apr 6, 2022

Relapsed/Refractory Follicular Lymphoma With EZH2 Trial in Shanghai (Tazemetostat)

Not yet recruiting
  • Relapsed/Refractory Follicular Lymphoma With EZH2
  • Tazemetostat
  • Shanghai, Shanghai, China
    Shanghai Cancer Center
Jul 20, 2022

Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (Tazemetostat, Pembrolizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 26, 2022

Recurrent DLBCL Germinal Center B-Cell Type, Recurrent Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma Trial (Belinostat,

Not yet recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
  • +5 more
  • (no location specified)
Dec 2, 2022

Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Talazoparib, Tazemetostat)

Recruiting
  • Metastatic Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Jul 18, 2022

Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant

Recruiting
  • Atypical Teratoid Rhabdoid Tumor
  • +6 more
  • Tazemetostat
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 23, 2023

Non Small Cell Lung Cancer Trial in West Los Angeles (Tazemetostat)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Tazemetostat
  • West Los Angeles, California
    VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Jul 21, 2022

Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Duarte (Tazemetostat, Ublituximab, Umbralisib)

Not yet recruiting
  • Recurrent Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Tazemetostat
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jul 31, 2022

Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

Temporarily not available
  • Epithelioid Sarcoma (Ex-US Only)
  • +19 more
  • Tazemetostat
  • (no location specified)
Oct 17, 2022

Relapsed/Refractory Trial in Santa Fe (Tafasitamab, Lenalidomide, Tazemetostat)

Recruiting
  • Relapsed/Refractory
  • Santa Fe, California
    California Cancer Associates For Research And Excellence, cCARE
Feb 23, 2022

Sinonasal Carcinoma Trial (drug, procedure, other)

Not yet recruiting
  • Sinonasal Carcinoma
  • (no location specified)
Dec 9, 2021

COVID-19 Acute Respiratory Distress Syndrome, Cytokine Release Syndrome Trial (Tazemetostat)

Withdrawn
  • COVID-19 Acute Respiratory Distress Syndrome
  • Cytokine Release Syndrome
  • Tazemetostat
  • (no location specified)
Nov 17, 2021

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Trial in Japan (Tazemetostat)

Completed
  • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
  • Tazemetostat
  • Nagoya, Aichi, Japan
  • +27 more
Nov 18, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Jan 13, 2023

All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,

Active, not recruiting
  • All Malignancies
  • +11 more
  • Tazemetostat
  • +2 more
  • Encinitas, California
  • +9 more
May 20, 2022

B-cell Lymphomas (Phase 1), Advanced Solid Tumors (Phase 1), Diffuse Large B-cell Lymphoma (Phase 2) Trial in Worldwide

Completed
  • B-cell Lymphomas (Phase 1)
  • +5 more
  • Tazemetostat
  • Birmingham, Alabama
  • +51 more
Dec 8, 2021

Follicular Lymphoma Trial in United States (Tazemetostat, Rituximab)

Recruiting
  • Follicular Lymphoma
  • Tazemetostat
  • Rituximab
  • Birmingham, Alabama
  • +19 more
Mar 29, 2022

Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle Cell Lymphoma Trial in Tucson, Tampa, New York

Completed
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • Tazemetostat
  • +3 more
  • Tucson, Arizona
  • +2 more
Mar 23, 2021